Customer performed an autologous cd34 enrichment with low number of cd34 cells in beginning (42x10e6) from total 2.4x10e10 wbcs.Process control code was fine.The target obtained 11.4x10e8 total cells with only a cd34 purity of 1%.This is in total 11.8x10e6 cd34 cells and a cd34 yield of 28%.Both, the purity and yield does not match the customers and patients need.Finally, the patient was not treated with an experimental treatment.No more information on the patient was provided by the customer.The investigation revealed a suboptimal starting material with a very low frequency of stem cells and a low total number of cells.This has a huge influence on the performance.Important data to fully understand the case were not delivered by the customer (analysis of waste fraction).
|